- Home
- ENVB vs ASTI Comparison
ENVB vs ASTI Comparison
Compare ENVB & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- ASTI
- Stock Information
- Founded
- ENVB 1994
- ASTI 2005
- Country
- ENVB United States
- ASTI United States
- Employees
- ENVB N/A
- ASTI N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- ASTI Semiconductors
- Sector
- ENVB Health Care
- ASTI Technology
- Exchange
- ENVB Nasdaq
- ASTI Nasdaq
- Market Cap
- ENVB 3.3M
- ASTI 3.1M
- IPO Year
- ENVB N/A
- ASTI N/A
- Fundamental
- Price
- ENVB $1.36
- ASTI $2.21
- Analyst Decision
- ENVB
- ASTI
- Analyst Count
- ENVB 0
- ASTI 0
- Target Price
- ENVB N/A
- ASTI N/A
- AVG Volume (30 Days)
- ENVB 564.4K
- ASTI 29.2K
- Earning Date
- ENVB 03-25-2025
- ASTI 03-04-2025
- Dividend Yield
- ENVB N/A
- ASTI N/A
- EPS Growth
- ENVB N/A
- ASTI N/A
- EPS
- ENVB N/A
- ASTI N/A
- Revenue
- ENVB N/A
- ASTI $44,673.00
- Revenue This Year
- ENVB N/A
- ASTI N/A
- Revenue Next Year
- ENVB N/A
- ASTI N/A
- P/E Ratio
- ENVB N/A
- ASTI N/A
- Revenue Growth
- ENVB N/A
- ASTI N/A
- 52 Week Low
- ENVB $1.26
- ASTI $1.90
- 52 Week High
- ENVB $657.00
- ASTI $87.80
- Technical
- Relative Strength Index (RSI)
- ENVB 16.91
- ASTI 43.64
- Support Level
- ENVB $1.26
- ASTI $2.14
- Resistance Level
- ENVB $1.70
- ASTI $2.49
- Average True Range (ATR)
- ENVB 0.17
- ASTI 0.21
- MACD
- ENVB 2.34
- ASTI 0.02
- Stochastic Oscillator
- ENVB 12.20
- ASTI 52.54
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.